Nurtec ODT 75 MG tablet 8S
Ended Awarded Last action
- Contract number
- SPE2DR26F4ZWX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,042
Award facts
- Contract value 100% obligated
- $52,042.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 28, 2026, the Defense Logistics Agency awarded a delivery order valued at $52,042.22 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packaging). The contract, which is not set-aside and competitively awarded, is structured as a firm fixed-price delivery order with an ultimate completion date of January 29, 2026. Performance will be executed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving critical federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to supply a wide range of pharmaceutical products and medical commodities across multiple therapeutic domains. NURTEC ODT is a migraine treatment medication, consistent with AmerisourceBergen's delivery of specialized neurological treatments and other therapeutic medications to support military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F4ZWX?
SPE2DR26F4ZWX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F4ZWX worth?
The government has obligated $52,042 on SPE2DR26F4ZWX.
Is contract SPE2DR26F4ZWX an order under another contract?
Yes. SPE2DR26F4ZWX is a delivery order under SPE2DR25D2010, an indefinite delivery contract.
Was contract SPE2DR26F4ZWX competed?
The extent of competition for SPE2DR26F4ZWX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award